Review



retrograde aav1 syn jgcamp8s wpre  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Addgene inc retrograde aav1 syn jgcamp8s wpre
    Retrograde Aav1 Syn Jgcamp8s Wpre, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 175 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrograde aav1 syn jgcamp8s wpre/product/Addgene inc
    Average 96 stars, based on 175 article reviews
    retrograde aav1 syn jgcamp8s wpre - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    86
    Charles River Laboratories aav1 gfp virus
    Aav1 Gfp Virus, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav1 gfp virus/product/Charles River Laboratories
    Average 86 stars, based on 1 article reviews
    aav1 gfp virus - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    96
    Addgene inc retrograde aav1 syn jgcamp8s wpre
    Retrograde Aav1 Syn Jgcamp8s Wpre, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrograde aav1 syn jgcamp8s wpre/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    retrograde aav1 syn jgcamp8s wpre - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc aav1
    Aav1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav1/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    aav1 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    86
    Vigene Biosciences aav1
    Aav1, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav1/product/Vigene Biosciences
    Average 86 stars, based on 1 article reviews
    aav1 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Vigene Biosciences aav1 icam2 shdpep1
    Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
    Aav1 Icam2 Shdpep1, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav1 icam2 shdpep1/product/Vigene Biosciences
    Average 86 stars, based on 1 article reviews
    aav1 icam2 shdpep1 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Vigene Biosciences aav1 scramble
    Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
    Aav1 Scramble, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav1 scramble/product/Vigene Biosciences
    Average 86 stars, based on 1 article reviews
    aav1 scramble - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    91
    Addgene inc aav1 flexpkialpha ires nls mruby2
    Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
    Aav1 Flexpkialpha Ires Nls Mruby2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav1 flexpkialpha ires nls mruby2/product/Addgene inc
    Average 91 stars, based on 1 article reviews
    aav1 flexpkialpha ires nls mruby2 - by Bioz Stars, 2026-05
    91/100 stars
      Buy from Supplier

    93
    Addgene inc paav ef1a dio mscarlet aav1
    Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
    Paav Ef1a Dio Mscarlet Aav1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/paav ef1a dio mscarlet aav1/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    paav ef1a dio mscarlet aav1 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    96
    Addgene inc aav1 ef1a dio hchr2 h134r eyfp wpre hgh
    Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
    Aav1 Ef1a Dio Hchr2 H134r Eyfp Wpre Hgh, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav1 ef1a dio hchr2 h134r eyfp wpre hgh/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    aav1 ef1a dio hchr2 h134r eyfp wpre hgh - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    93
    Addgene inc paav syn flex jgcamp7b wpre aav1
    Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview <t>of</t> <t>intravenous</t> <t>AAV1‐ICAM2‐shDpep1</t> injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.
    Paav Syn Flex Jgcamp7b Wpre Aav1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/paav syn flex jgcamp7b wpre aav1/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    paav syn flex jgcamp7b wpre aav1 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview of intravenous AAV1‐ICAM2‐shDpep1 injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.

    Journal: MedComm

    Article Title: Spatially Characterized Aortic Proteome Reveals Novel Regional Signatures and Glucocorticoid Receptor/Dipeptidase 1 Axis in Diabetic Vasculopathy

    doi: 10.1002/mco2.70714

    Figure Lengend Snippet: Vascular inflammation and endothelial dysfunction driven by diabetes‐related Dpep1 upregulation. (A) Western blotting on Dpep1 expression in TA and AA from C57BL/6 mice following ex vivo treatment with HG and LPS, and corresponding quantification. (B) Western blotting on DPEP1 expression in HG‐ and LPS‐treated HAECs, and corresponding quantification. (C) Schematic overview of chronic cilastatin treatment in diabetic mice. (D) Western blotting on Dpep1 expression in TA and AA from nondiabetic and diabetic mice following chronic cilastatin treatment ( n = 4 per group). (E) Dpep1 activity in TA, and (F) MPO activity in TA and AA from db/m + and db/db mice following chronic cilastatin treatment. (G) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas after cilastatin treatment. (H) Functional assay on EDRs of aortas from cilastatin‐treated mice by wire myograph ( n = 5 per group). (I) Schematic overview of intravenous AAV1‐ICAM2‐shDpep1 injection in diabetic mice. (J) Western blotting on Dpep1 expression in isolated endothelial cells from TA and AA of nondiabetic and diabetic mice subjected to AAV‐shDpep1 injection, and corresponding quantification ( n = 4 per group). (K) MPO activity in TA and AA from AAV‐shDpep1‐injected db/m + and db/db mice. (L) Heatmap on the RT‐PCR results of inflammatory markers in mouse aortas from AAV‐shDpep1‐injected mice. (M) Functional assay on EDRs of aortas from AAV‐shDpep1‐injected mice by wire myograph ( n = 5 per group). (N) Schematic overview of diabetes‐related endothelial Dpep1 upregulation and neutrophil‐released MPO in promoting vascular inflammation and endothelial dysfunction. Data are presented as mean ± SD. * p < 0.05 (Brown–Forsythe and Welch ANOVA, and unpaired t with Welch's correction). AA, abdominal aorta; AAV, adeno‐associated virus; ACh, acetylcholine; DPEP1, dipeptidase 1; EC, endothelial cell; HAEC, human aortic endothelial cell; HG, high glucose; IV, intravenous; LPS, lipopolysaccharide; MPO, myeloperoxidase; Phe, phenylephrine; TA, descending thoracic aorta.

    Article Snippet: For AAV‐mediated Dpep1 knockdown in vivo, some db/m + and db/db mice were intravenously injected with AAV1‐scramble or AAV1‐ICAM2‐shDpep1 (2 × 10 11 vg per mouse), generated by Vigene Biosciences (Maryland, USA).

    Techniques: Western Blot, Expressing, Ex Vivo, Activity Assay, Reverse Transcription Polymerase Chain Reaction, Functional Assay, Injection, Isolation, Virus